Ultragenyx Pharmaceutical Inc at Cowen and Company Health Care Conference Transcript
Hey, good morning, everybody. And thanks for joining us on this second day here at the Cowen -- the 39th Annual Cowen Healthcare Conference in Boston. It's a great pleasure to introduce Emil Kakkis, CEO and President of Ultragenyx. Emil has founded the Company after founding originally BioMarin. And Ultragenyx is one of our topics for this year. So I think there is going to be a presentation here, and there's going to be a breakout session at the Exeter Room across the hall.
So, Emil, thank you for joining us. We appreciate it.
Thanks, Yaron. It's been a long time. And good to see you back, back in the fold. So good morning, everyone. And we will give you an update on Ultragenyx in the last while.
Ultragenyx, a rare disease company, by design, from the beginning. How do you build the best rare disease company? You can. And we have been doing that with a number of new approaches which I'll touch on. We've also been building a gene therapy
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
